Processa Pharmaceuticals (PCSA) had the highest return in March 2014 by a US stock, returning 2,401,860.8%.

ASSET	MONTH	% RETURN
Processa Pharmaceuticals (PCSA)	March 2014	2,401,860.78%
Lexaria Bioscience (LEXX)	March 2014	623.09%
CEA Industries (BNC)	March 2014	419.87%
SurgePays (SURG)	March 2014	393.83%
Empire Petroleum (EP)	March 2014	220%
Perspective Therapeutics (CATX)	March 2014	182.05%
Green Brick Partners (GRBK)	March 2014	151.73%
CervoMed (CRVO)	March 2014	131.66%
Actinium Pharmaceuticals (ATNM)	March 2014	124.32%
Celsius (CELH)	March 2014	97.7%
AudioEye (AEYE)	March 2014	89.26%
Ryvyl (RVYL)	March 2014	77.28%
Iovance Biotherapeutics (IOVA)	March 2014	76.45%
Aemetis (AMTX)	March 2014	75.76%
BIO-Key International (BKYI)	March 2014	71.88%
Nextplat (NXPL)	March 2014	66.67%
VistaGen Therapeutics (VTGN)	March 2014	61.33%
Barfresh Food (BRFH)	March 2014	60.75%
374Water Inc Common Stock (SCWO)	March 2014	60%
Nephros (NEPH)	March 2014	58.02%
Energous (WATT)	March 2014	55.26%
Plug Power (PLUG)	March 2014	54.35%
Soluna (SLNH)	March 2014	52.52%
CarParts (PRTS)	March 2014	49.27%
Abeona Therapeutics (ABEO)	March 2014	48.65%